- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/20 - Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Patent holdings for IPC class C07D 333/20
Total number of patents in this class: 516
10-year publication summary
|
31
|
36
|
35
|
26
|
20
|
22
|
9
|
27
|
17
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The General Hospital Corporation | 4881 |
10 |
| Takeda Pharmaceutical Company Limited | 2698 |
8 |
| Shanghai Leado PharmaTech Co. Ltd. | 17 |
8 |
| The Broad Institute, Inc. | 1991 |
7 |
| Newron Pharmaceuticals S.p.A. | 56 |
7 |
| Immunomet Therapeutics Inc. | 31 |
6 |
| Texas Heart Institute | 117 |
6 |
| UCB Pharma GmbH | 77 |
6 |
| Regenacy Pharmaceuticals, LLC | 26 |
6 |
| The Regents of the University of California | 20868 |
5 |
| Syngenta Participations AG | 1484 |
5 |
| Massachusetts Institute of Technology | 10290 |
5 |
| Idemitsu Kosan Co., Ltd. | 4269 |
5 |
| President and Fellows of Harvard College | 6111 |
5 |
| Nippon Soda Co., Ltd. | 885 |
5 |
| Oryzon Genomics S.A. | 103 |
5 |
| Osaka University | 3258 |
5 |
| Centre National de La Recherche Scientifique | 11092 |
4 |
| Akaal Pharma Pty Ltd. | 11 |
4 |
| Council of Scientific & Industrial Research | 1447 |
4 |
| Other owners | 400 |